Overview
Yoshiki Hase practices in Newcastle Upon Tyne, United Kingdom. Mr. Hase is rated as a Distinguished expert by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Vascular Dementia, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, CACH Syndrome, and Dementia.
His clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of CACH Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Vascular DementiaMr. Hase isElite. Learn about Vascular Dementia.
- Distinguished
- CACH SyndromeMr. Hase isDistinguished. Learn about CACH Syndrome.
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
- Advanced
- Carotid Artery DiseaseMr. Hase isAdvanced. Learn about Carotid Artery Disease.
- DementiaMr. Hase isAdvanced. Learn about Dementia.
- Experienced
- Alzheimer's DiseaseMr. Hase isExperienced. Learn about Alzheimer's Disease.
- Lewy Body Dementia (LBD)Mr. Hase isExperienced. Learn about Lewy Body Dementia (LBD).
- Low Blood PressureMr. Hase isExperienced. Learn about Low Blood Pressure.
- Parkinson's DiseaseMr. Hase isExperienced. Learn about Parkinson's Disease.
- StrokeMr. Hase isExperienced. Learn about Stroke.